RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 69 filers reported holding RAPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $275 | -98.6% | 90 | -88.6% | 0.00% | – |
| Q4 2023 | $19,647 | +474.1% | 791 | +284.0% | 0.00% | – |
| Q3 2023 | $3,422 | -47.8% | 206 | -36.6% | 0.00% | – |
| Q2 2023 | $6,555 | +18.1% | 325 | 0.0% | 0.00% | – |
| Q1 2023 | $5,549 | +38.7% | 325 | +62.5% | 0.00% | – |
| Q4 2022 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -99.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $401,000 | +4912.5% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | +33.3% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -72.7% | 200 | -80.0% | 0.00% | – |
| Q1 2021 | $22,000 | +10.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $20,000 | +300.0% | 1,000 | +566.7% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 150 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 150 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $49,662,000 | 44.09% |
| KPCB XV Associates, LLC | 1,297,063 | $40,274,000 | 30.08% |
| Euclidean Capital LLC | 635,177 | $19,722,000 | 9.59% |
| Ponoi II Management, LLC | 145,401 | $4,515,000 | 6.69% |
| Column Group LLC | 1,402,008 | $43,532,000 | 4.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $35,655,000 | 4.34% |
| Trustees of Columbia University in the City of New York | 73,383 | $2,279,000 | 3.48% |
| Ghost Tree Capital, LLC | 250,000 | $7,763,000 | 2.27% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 608,663 | $18,899,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,090,000 | 1.99% |